Skip to main content
. Author manuscript; available in PMC: 2019 Sep 10.
Published in final edited form as: JAMA Pediatr. 2018 Nov 1;172(11):1029–1037. doi: 10.1001/jamapediatrics.2018.2143

Table 3.

Retention in care among youth with at least two claims for addiction treatment.

Characteristic Adjusteda HR (95% CI)
Attrition from
Any Addiction
Treatmentb,c
(n = 3,247)
Attrition from
Behavioral Health
Servicesb
(n = 2,885)
Sociodemographic characteristics
Age ≥21 years 1.63 (1.45 – 1.83) 1.59 (1.41 – 1.80)
Male sex 1.13 (1.03 – 1.24) 1.13 (1.02 – 1.24)
Non-Hispanic white 1.03 (0.93 – 1.14) 1.05 (0.94 – 1.18)
Medicaid-eligible due to disability 0.63 (0.49 – 0.80) 0.60 (0.46 – 0.78)
Clinical characteristics
Pregnancyd 0.87 (0.75 – 0.99) 0.90 (0.77 – 1.04)
Comorbid behavioral health diagnosis (depression,
anxiety, or attention deficit hyperactivity disorder)d
1.04 (0.95 – 1.14) 1.01 (0.92 – 1.11)
Comorbid alcohol or other substance use disorderd 1.02 (0.93 – 1.12) 1.00 (0.91 – 1.10)
Acute or chronic pain conditiond 0.92 (0.84 – 1.01) 0.92 (0.83 – 1.01)
Treatment received
Higher level of behavioral health servicese within 3
months of initiating episode of care
0.94 (0.85 – 1.02) 0.92 (0.83 – 1.01)
Received timely OUD medication within 3 months of
diagnosis
 No medication Reference Reference
 Buprenorphine 0.58 (0.52 – 0.64) 0.73 (0.64 – 0.82)
 Naltrexone 0.54 (0.43 – 0.69) 0.57 (0.44 – 0.73)
 Methadone 0.32 (0.22 – 0.47) 0.47 (0.33 – 0.68)
a.

Multivariable models included all covariates listed in table

b.

Attrition defined as ≥60 days without any claims for services

c.

Includes receipt of any behavioral health services or OUD medications

d.

At or during the three months prior to receiving OUD diagnosis

e.

Includes intensive outpatient treatment, partial hospitalization, residential care, or inpatient care